Tre recombinase

Last updated

Tre recombinase is an experimental enzyme that in lab tests has removed DNA inserted by HIV from infected cells. [1] Through selective mutation, Cre recombinase which recognizes loxP sites are modified to identify HIV long terminal repeats (loxLTR) instead. As a result, instead of performing Cre-Lox recombination, the new enzyme performs recombination at HIV provirus sites. [2]

The structure of Tre in complex with loxLTR has been resolved ( PDB: 5U91 ​), allowing for analyzing the roles of individual mutations. [3]

References

  1. ↑ Sarkar, Indrani; Hauber, Ilona; Hauber, Joachim; Buchholz, Frank (2007). "HIV-1 proviral DNA excision using an evolved recombinase". Science . 316 (5833): 1912–15. Bibcode:2007Sci...316.1912S. doi:10.1126/science.1141453. PMID   17600219. S2CID   2437602.
  2. ↑ Hauber, Ilona; Hofmann-Sieber, Helga; Chemnitz, Jan; et al. (September 26, 2013). "Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice". PLOS Pathogens. 9 (9) e1003587. doi: 10.1371/journal.ppat.1003587 . PMC   3784474 . PMID   24086129.
  3. ↑ Meinke, G; Karpinski, J; Buchholz, F; Bohm, A (19 September 2017). "Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA". Nucleic Acids Research. 45 (16): 9726–9740. doi: 10.1093/nar/gkx603 . PMC   5766204 . PMID   28934476.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.